Replies to post #205213 on Biotech Values

[DewDiligence]

PRPO seeks patent on gynecologic-cancer diagnostic:

https://globenewswire.com/news-release/2018/03/28/1454558/0/en/Precipio-Files-Patent-for-Non-Invasive-Cell-Capture-Device-For-Gynecological-Cancer-Detection.html

Internally named “Juno” (after the Roman goddess of fertility) and developed by Precipio’s R&D team in collaboration with Dr. Gil Mor, Yale University Professor of Obstetrics and Gynecology, Juno is a proprietary panty liner device that, in internal testing, we believe has successfully demonstrated the ability to collect and preserve cells from vaginal discharge, potentially enabling the identification of abnormal cells that may indicate the presence of cancer.

This is the first mention of PRPO on this board since it went public via a reverse merger in 2016 (#msg-125767889).